Volume 26, Issue 3 (5-2019)
RJMS 2019, 26(3): 88-97 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Aminimoghaddam S, Abolghasem N, Maghsoudnia A. upper genital tract infection : A review. RJMS 2019; 26 (3) :88-97
URL: http://rjms.iums.ac.ir/article-1-5454-en.html
URL: http://rjms.iums.ac.ir/article-1-5454-en.html
Department of Gynecology Oncology, Iran University of Medical Sciences, Tehran, Iran , aminimoghaddam.s@iums.ac.ir
Abstract: (4906 Views)
Upper genital tract infection causes inflammation in multiple organs such as endometrium, fallopian tubes, ovaries, and pelvic peritoneum. This type of disease is caused due to infection with cervical pathogens, such as Neisseria gonorrhea, Chlamydia trachomatis, Mycoplasma genitalium, bacterial vaginosis pathogens, and respiratory pathogens. The pathogens which involve the respiratory system and cervix are streptococci type A and enteric pathogens. The primary goal of this study is reviewing reasons for having cervicitis and upper genital tract infection by discussing the appropriate treatments. Pelvic Inflammatory disease is one of the major topics of this field which needs a review since it engenders multiple disorders such as chronic pelvic pain, infertility, and ectopic pregnancy. Moreover, even by performing a treatment, there is a good chance of seeing sequela and scar in the fallopian tube in such patients. It should be noted that although recent progress in detecting/treatment of the infection during the early stages, infertility caused by PID is a major concern for health system. Additionally, subclinical PID remains poorly controlled, which needs more attention. In developing country Prevention programs, such as chlamydia screening or vaccination, should be developed to mitigate the infection problems.
Type of Study: review article |
Subject:
Gynecology
References
1. 1. Brunham RC, Gottlieb SL, Paavonen J. Pelvic inflammatory disease. New England Journal of Medicine. 2015;372(21):2039-48.
2. 2. Bartlett EC, Levison WB, Munday PE. Pelvic inflammatory disease. Bmj. 2013;346:f3189.
3. 3. Wiesenfeld HC, Hillier SL, Krohn MA, Amortegui AJ, Heine RP, Landers DV, et al. Lower genital tract infection and endometritis: insight into subclinical pelvic inflammatory disease. Obstetrics & Gynecology. 2002;100(3):456-63.
4. 4. Aminimoghaddam S, Batayee S, Maghsoudnia A, Mohammadi M. Update of Vaginitis for obstetricians: A Review. Razi Journal of Medical Sciences. 2018;24(163):0-.
5. 5. Samantaray S, Parida G, Rout N, Giri SK, Kar R. Cytologic detection of tuberculous cervicitis. Acta cytologica. 2009;53(5):594-6.
6. 6. Gaydos C, Maldeis NE, Hardick A, Hardick J, Quinn TC. Mycoplasma genitalium as a contributor to the multiple etiologies of cervicitis in women attending sexually transmitted disease clinics. Sexually transmitted diseases. 2009;36(10):598.
7. 7. Bjartling C, Osser S, Persson K. Mycoplasma genitalium in cervicitis and pelvic inflammatory disease among women at a gynecologic outpatient service. American journal of obstetrics and gynecology. 2012;206(6):476. e1-. e8.
8. 8. Workowski KA. Centers for Disease Control and Prevention sexually transmitted diseases treatment guidelines. Clinical Infectious Diseases. 2015;61(suppl_8):S759-S62.
9. 9. Rodrigues M, Fernandes P, Haddad J, Paiva M, Souza MDCM, Andrade T, et al. Frequency of Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium, Mycoplasma hominis and Ureaplasma species in cervical samples. Journal of Obstetrics and Gynaecology. 2011;31(3):237-41.
10. 10. Lis R, Rowhani-Rahbar A, Manhart LE. Mycoplasma genitalium infection and female reproductive tract disease: a meta-analysis. Clinical Infectious Diseases. 2015;61(3):418-26.
11. 11. Paraskevaides E, Wilson MC. Fatal disseminated intravascular coagulation secondary to streptococcal cervicitis. European Journal of Obstetrics & Gynecology. 1988;29(1):39-40.
12. 12. Aminimoghaddam S. A Review of Recent Findings for Obstetricians about Combined Oral Contraceptive Pills. Journal of Obstetrics, Gynecology and Cancer Research. 2017;2(2).
13. 13. Manhart LE, Critchlow CW, Holmes KK, Dutro SM, Eschenbach DA, Stevens CE, et al. Mucopurulent cervicitis and Mycoplasma genitalium. The Journal of infectious diseases. 2003;187(4):650-7.
14. 14. Ross J, Judlin P, Jensen J. 2012 European guideline for the management of pelvic inflammatory disease. International journal of STD & AIDS. 2014;25(1):1-7.
15. 15. Johnson LF, Lewis DA. The effect of genital tract infections on HIV-1 shedding in the genital tract: a systematic review and meta-analysis. Sexually transmitted diseases. 2008;35(11):946-59.
16. 16. Paavonen J, Critchlow CW, DeRouen T, Stevens CE, Kiviat N, Brunham RC, et al. Etiology of cervical inflammation. American journal of obstetrics and gynecology. 1986;154(3):556-64.
17. 17. Aminimoghaddam S. The 2014 Bethesda System and Pap-Smear. Obstet Gynecol. 2016;1(2):e7946.
18. 18. Marrazzo JM, Wiesenfeld HC, Murray PJ, Busse B, Meyn L, Krohn M, et al. Risk factors for cervicitis among women with bacterial vaginosis. The Journal of infectious diseases. 2006;193(5):617-24.
19. 19. Olson S, McComb PF. Formation of Fitz-Hugh Curtis adhesions due to perihepatitis associated with salpingitis. J Obstet Gynaecol Can. 2010;32(6):533-4.
20. 20. Korn AP, Hessol NA, Padian NS, Bolan GA, Donegan E, Landers DV, et al. Risk factors for plasma cell endometritis among women with cervical Neisseria gonorrhoeae, cervical Chlamydia trachomatis, or bacterial vaginosis. American journal of obstetrics and gynecology. 1998;178(5):987-90.
21. 21. Wiesenfeld HC, Sweet RL, Ness RB, Krohn MA, Amortegui AJ, Hillier SL. Comparison of acute and subclinical pelvic inflammatory disease. Sexually transmitted diseases. 2005;32(7):400-5.
22. 22. Tepper NK, Steenland MW, Gaffield ME, Marchbanks PA, Curtis KM. Retention of intrauterine devices in women who acquire pelvic inflammatory disease: a systematic review. Contraception. 2013;87(5):655-60.
23. 23. Peipert JF, Ness RB, Blume J, Soper DE, Holley R, Randall H, et al. Clinical predictors of endometritis in women with symptoms and signs of pelvic inflammatory disease. American journal of obstetrics and gynecology. 2001;184(5):856-64.
24. 24. Brunham RC, Rappuoli R. Chlamydia trachomatis control requires a vaccine. Vaccine. 2013;31(15):1892-7.
25. 25. Aminimoghaddam S, Mahmoudzadeh F, Maghsoudnia A. Cervical cancer along with unknown cirrhosis: a misdiagnosed case. Journal of reproduction & infertility. 2015;16(3):174.
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
